Clinical Trial Update: A Study to Evaluate the Efficacy and Toxicities of PLX038, in Patients With Locally Advanced or Metastatic Triple-negative Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating PLX038 for locally advanced or metastatic triple-negative breast cancer has been terminated, according to the clinical trial update f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• PLX038

Snippet

Sponsor: Institut Curie | Conditions: Breast, Cancer | Phase 2 | Status: TERMINATED